spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Cell Line Development and Engineering

23-25 April 2018
RAI, Amsterdam

Cell Line Development & Engineering 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe.

With 900+ attendees, 275+ companies and over 70 sessions showcasing new data and technologies, this year is one not to be missed! Premier industry-led cell line development and engineering event – 3 days dedicated to cutting edge science, technologies and strategies:
Day One: Monoclonality & Complex Molecules
Day Two: Cell Line & Host Cell Engineering
Day Three: Automation & Manufacturability Assessment

SIGN UP NOW AND SAVE MORE: https://lifesciences.knect365.com/cell-line-congress/?vip_code=CQ3568EBR

Contact:
T: +44 (0) 20 3377 3279
E: LS.Registrations@Knect365.com 

 
Print this page
Send to a friend
   
spacer
Industry Events

ELRIG Drug Discovery 2019 – Looking Back to the Future

5-6 November 2019, ACC, Liverpool

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC in Liverpool. This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.
More info >>

White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>


News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement